Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.)

Rabe T; Luxembourg B; Ludwig M; Dinger JC; Bauersachs R; Rott H; Mueck AO; Albring C

Rabe T, Luxembourg B, Ludwig M, Dinger JC, Bauersachs R, Rott H, Mueck AO, Albring C
Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.)
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2011; 8 (Sonderheft 1): 178-218

Volltext (PDF) Summary Übersicht

Abbildung 10a,b: VTE risk - Contraceptives
Flow diagram for assessing VTE risk (based on family/patient history and thrombophilia tests) in choice of contraceptive. Source: T. Rabe

Vorheriges Bild

Nächstes Bild

Abbildung 10a,b: VTE risk - Contraceptives
Flow diagram for assessing VTE risk (based on family/patient history and thrombophilia tests) in choice of contraceptive. Source: T. Rabe